Clinical Trial Update: Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis

View source ↗

Summary

Clinical trial evaluating rifampicin resistance in Staphylococcus aureus during and after treatment for latent tuberculosis is currently recruiting in the Regio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Staphylococcus Aureus Infection

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Region Skane | Conditions: Latent Tuberculosis, Staphylococcus Aureus | Status: RECRUITING